Adaptimmune Therapeutics shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $744 | 5.7k | 0.13 |
| 2025-06-30 | $2.0k | 8.5k | 0.24 |
| 2025-03-31 | $3.6k | 18k | 0.20 |
| 2024-12-31 | $11k | 20k | 0.54 |
| 2024-09-30 | $18k | 19k | 0.95 |
| 2024-06-30 | $16k | 17k | 0.97 |
| 2024-03-31 | $11k | 7.1k | 1.58 |
| 2023-12-31 | $4.7k | 5.9k | 0.79 |
| 2023-09-30 | $4.4k | 5.6k | 0.78 |
| 2023-06-30 | $5.2k | 5.6k | 0.92 |